A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

NCT06982859 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Insulin Sensitivity

Interventions

DRUG: Retatrutide
DRUG: Semaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company